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ABSTRACT
Marburg virus (MARV), which belongs to the virus family Filoviridae, causes hemorrhagic fever in humans and nonhuman pri-
mates that is often fatal. MARV is a lipid-enveloped virus that during the replication process extracts its lipid coat from the
plasmamembrane of the host cell it infects. MARV carries seven genes, one of which encodes its matrix protein VP40 (mVP40),
which regulates the assembly and budding of the virions. Currently, little information is available onmVP40 lipid binding prop-
erties. Here, we have investigated the in vitro and cellular mechanisms by which mVP40 associates with lipid membranes.
mVP40 associates with anionic membranes in a nonspecific manner that is dependent upon the anionic charge density of the
membrane. These results are consistent with recent structural determination of mVP40, which elucidated anmVP40 dimer with
a flat and extensive cationic lipid binding interface.
IMPORTANCE
Marburg virus (MARV) is a lipid-enveloped filamentous virus from the family Filoviridae. MARVwas discovered in 1967, and
yet little is known about how its seven genes are used to assemble and form a new viral particle in the host cell it infects. The
MARVmatrix protein VP40 (mVP40) underlies the inner leaflet of the virus and regulates budding from the host cell plasma
membrane. In vitro and cellular assays in this study investigated the mechanism by which mVP40 associates with lipids. The
results demonstrate that mVP40 interactions with lipid vesicles or the inner leaflet of the plasmamembrane are electrostatic but
nonspecific in nature and are dependent on the anionic charge density of the membrane surface. Small molecules that can dis-
rupt lipid trafficking or reduce the anionic charge of the plasmamembrane interface may be useful in inhibiting assembly and
budding of MARV.
Marburg virus (MARV) and Ebola virus (EBOV) aremembersof the virus family Filoviridae that are characterized by their
filamentous lipid -enveloped morphology (1). Electron micros-
copy studies revealed that MARV particles have a uniform diam-
eter of approximately 80 nm,with an average particle length of 740
nm (2, 3). MARV harbors a negative-sense RNA genome 19.1 kb
in length that includes seven genes (4). The glycoprotein (GP) is a
transmembrane protein present in the viral envelope, and it me-
diates viral entry into the host cell. VP40 is the major matrix pro-
tein (mVP40) and completely underlies the lipid envelope of the
virus. VP40 alone is sufficient to produce virus-like particles
(VLPs) from mammalian cells that are nearly indistinguishable
from virions (5–8). In addition to interacting with the host cell
membrane and mediating budding, VP40 interacts with the nu-
cleocapsid, which consists of nucleoprotein, VP24, VP30, VP35,
and the L protein (9). VP40 also plays other essential roles, such as
immunosuppression (10), regulation of viral transcription,
and/or replication (11, 12), and is also able to interact with GP,
coexpression of which leads to GP enrichment at sites of mVP40
budding (13).
mVP40 is a peripheral protein that is trafficked to the plasma
membrane along the retrograde late endosomal pathway (14).
This trafficking mechanism is likely different than that of the
EBOVVP40matrix protein (eVP40), which has been shown to be
transported in a COPII vesicle-dependent manner (15). mVP40
and eVP40 are 34% identical (49% homologous) in amino acid
sequence, which suggests they may have some different interac-
tions with host cell proteins or lipids. eVP40 harbors an N-termi-
nal domain (NTD) involved in oligomerization (16–19) and a
C-terminal domain (CTD) reported to mediate membrane bind-
ing (20–25). Recent structural analyses of eVP40 (21) andmVP40
(26) have revealed an NTD interface that mediates dimerization,
which is required for VP40 plasma membrane localization and
budding. TheNTDs have 42% sequence identity and similar folds,
while the CTD is only 15% identical in sequence and somewhat
different in structure (26). This suggests that eVP40 and mVP40
may have different membrane binding properties mediated by
CTD interactions with the plasma membrane interface.
The inner leaflet of the plasma membrane is enriched in an-
ionic phospholipids, including phosphatidylserine (PS) (27),
phosphatidylinositol-4-phosphate [PI(4)P] (28), and phosphati-
dylinositol-4,5-bisphosphate [PI(4,5)P2] (29). These anionic
phospholipids, which comprise about 20 to 30 mol% of the
plasma membrane inner leaflet, provide platforms for peripheral
proteins tomediatemembrane association by using exposed basic
residues on the surface of the protein (30, 31). PS is the most
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abundant anionic phospholipid found at the inner leaflet of the
membrane, containing up to 15 to 20 mol% (32), and provides
points of attachment for peripheral proteins that contain specific
PS binding domains, such as C2 domains (33), or association with
proteins containing polybasic clusters through nonspecific elec-
trostatic interactions (34). Similarly, proteins that interact with
plasma membrane PI(4,5)P2 may do so with a specific binding
motif (35–37) or through nonspecific electrostatic interactions
(30, 31). Not surprisingly, several viral matrix proteins, including
eVP40 (20, 22–25, 38), have been shown to associate with anionic
lipids, such as PS andPI(4,5)P2, in vitro and in cells (39–46), which
is important in mediating their assembly and budding.
In this study, we employed in vitro lipid binding assays and
cellular localization analysis to investigate mVP40 lipid binding
properties. The results indicate thatmVP40 interacts with anionic
phospholipids in a nonspecific manner, functioning as an anionic
charge sensor. mVP40 binding to membranes is dependent upon
the anionic charge density of the plasma membrane, which when
neutralized ablates mVP40 localization. The binding and cellular
localization of mVP40 are consistent with recent structural anal-
ysis demonstrating thatmVP40 has a flat and extensive CTD basic
surface (26).
MATERIALS AND METHODS
Materials. All lipids were purchased from Avanti Polar Lipids (Alabaster,
AL) and used without further purification. Complete Mini-EDTA-free
protease inhibitor cocktail was from Roche (Indianapolis, IN), and phe-
nylmethylsulfonylfluoride (PMSF) and bicinchoninic acid (BCA) protein
assay kits were from Thermo Fisher Scientific (Waltham, MA). Lipo-
fectamine 2000 and Lipofectamine LTX were from Life Technologies
(Grand Island, NY). Ni-nitrilotriacetic acid (NTA) agarose was from
Qiagen (Valencia, CA).
mVP40-His tag in pET46 was a kind gift from E. Ollmann Saphire
(The Scripps Research Institute). The KR-–mRFP and GFP–R-Pre plas-
mids were a kind gift from Sergio Grinstein (University of Toronto), and
PLC-PH green fluorescent protein (GFP) was a kind gift from Tamas
Balla (NIH). Myc-5–phosphatase wild type (WT) and aMyc-5–phospha-
tase catalytically inactive deletionmutant were kind gifts from P.Majerus
(Washington University) (44, 47). Monomeric red fluorescent protein
(mRFP)-FKBP-pseudojanin (PJ-WT), mRFP-FKBP-Sac1, mRFP-FKBP-
INPP5E, and Lyn11-FRB-CFP (cyan fluorescent protein) were kind gifts
from Tamas Balla (NIH) and Gerald Hammond (University of Pitts-
burgh).
Protein purification. In order express andpurifymVP40, themVP40-
His tag pET46 plasmid was transformed into Escherichia coli Rosetta
(pLysS) cells. Successfully transformed pLysS cell colonies were used to
inoculate 3 ml of LBmedium containing 100g/ml ampicillin. This 3-ml
preculture was grown overnight at 37°C with shaking (200 rpm) and was
used to inoculate 1 liter LB medium containing 100 g/ml ampicillin.
Cells were grown with shaking (200 rpm) at 37°C until the optical density
at 600 nm reached 0.6. Expression of mVP40 protein was induced at 25°C
by treating the cells with 0.1 mM IPTG (isopropyl--D-thiogalactopyra-
noside) for 5 h or with 0.025 mM IPTG overnight. The cells were then
harvested by centrifugation at 6,000 g for 10 min. The cells were resus-
pended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imida-
zole, pH 8.0) and incubated for 15min after adding 100mMphenylmeth-
ylsulfonyl fluoride (PMSF) to a final concentration of 0.1 mM, lysozyme
to a final concentration of 1 mg/ml, and 10 l of 100 protease inhibitor
for each 10 ml of lysate buffer.
Following incubation, the lysate was sonicated at 4°C using multiple
short pulses (10 s) with pauses (30 s). The lysate was then centrifuged at
50,000  g for 20 min, and the supernatant was filtered sequentially
through 0.8-m and 0.45-m filters. The filtered supernatant was incu-
batedwithNi-NTA agarose resin for 1 h at 4°Cwith gentle shaking. Lysate
with the Ni-NTA resin was applied to a column, and the flowthrough was
discarded. The column was washed with 15 ml of wash buffer (50 mM
NaH2PO4, pH 8.0, containing 300 mM NaCl and 30 mM imidazole, pH
8.0), and the mVP40 protein was eluted with 7 ml of elution buffer (50
mM NaH2PO4, pH 8.0, containing 300 mM NaCl and 250 mM imida-
zole). The eluted proteinwas dialyzed overnight at 4°Cwith gentle stirring
against 25 mM HEPES, pH 7.4, containing 150 mM KCl. After dialysis,
mVP40 proteins were concentrated using a 10,000-Da Amicon ultracen-
trifugation filter (Merck Millipore Ltd., Billerica, MA) by centrifuging at
4,000 g.
MLV sedimentation assay. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol-
amine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS),
phosphatidylinositol derivatives (PIPs), and 1,2-dioleoyl-sn-glycero-3-
phosphate (PA) weremixed in the indicatedmolar ratios and dried under
N2 gas for 10min. In all sedimentation assays, 30%POPE, 20%POPS, and
5% PIPs were used tomaintain consistency (unless otherwise stated), and
POPC levels were scaled accordingly. Lipids were hydratedwith resuspen-
sion buffer (25 mM HEPES, pH 7.4, containing 150 mM KCl) and incu-
bated at 37°C for 15min to facilitate hydration of lipids to formvigorously
vortexed multilamellar vesicles (MLVs) (48–52). These lipid solutions
were then incubated with 5MmVP40 proteins at room temperature for
20 min. The total assay volume was 100 l, and the final lipid concentra-
tion was 1 mM. Samples were centrifuged at 48,000  g for 20 min.
During centrifugation,MARVVP40boundwithMLVs sedimented,while
unbound proteins remained in the supernatant. The supernatant was
carefully removed from the pellet, and the pellet was resuspended in an
amount of buffer equal to the volume that was removed as the superna-
tant. Forty microliters from each supernatant and pellet sample was sep-
arated by SDS-PAGE, and following staining with Coomassie brilliant
blue, gel band intensities were analyzed in the gel images using Image J
software. For quantification, the gel images were first converted to 8-bit
images using Image J software. Using the rectangular selection tool, a
rectangular region around the gel bands was selected and marked as the
first lane. By selecting plot lanes, the software creates a graphical repre-
sentation of the band intensities as peaks, and by using the wand tool, the
area under the peak for each gel band is obtained. The fraction of proteins
associated with MLVs of each lipid composition were calculated by the
following ratio: area under the peak for the pellet gel band divided by the
area under the peak for supernatant plus pellet gel bands. Each experiment
was performed at least three times to calculate amean, standard deviation
(SD) (or standard error of the mean [SEM] when indicated), and P value.
Cell culture. COS-7 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Invitrogen) containing 10% FBS and 1%Pen-
strep at 37°C in a 5% CO2 humidified incubator. The cells were grown to
70 to 80%confluence before passaging or transfection. Transfectionswere
performed using Lipofectamine 2000 reagent according to the manufac-
turer’s protocol.
Pharmacological treatments. Pharmacological treatments were per-
formed at 37°C unless otherwise noted. A sphingosine stock solution was
made by evaporation of chloroformunder nitrogen gas. The resulting film
was then resuspended in ethanol. Sphingosine was then added to cells in
culture to a final concentration of 75 M. Ethanol at the same final per-
centage as in the delivery experiment was used as the vehicle control.
Confocal imaging and analysis. Routine imaging of all cell lines was
performed on a Zeiss LSM 710 inverted microscope using a Plan Apo-
chromat 63 1.4-numerical-aperture oil objective, and either the 488-nm
or 561-nm laser line or both laser lines were used for colocalization/dual-
visualization experiments. The laser power was maintained constant dur-
ing the experiment (at 1.0), as were the gain and offset settings. Enhanced
green fluorescent protein (EGFP)was imaged using the 488-nm line of the
Ar ion laser, with the emission collected from 493- to 550-nm. mRFP was
excited with emission from the 561-nm laser line, and the emission was
collected from 600 to 700 nm. Unless otherwise stated, cells were imaged
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12 h posttransfection. In experiments where cells were imaged for quan-
tification for localization (mVP40, PLC-PH GFP, or KR-–mRFP), at
least 10 cells were imaged and quantified in each experiment, and three
replicates of each experiment were performed and averaged to calculate
the standard deviation (or standard error of themean, if indicated), aswell
as the P value. Image J software was used to assess the plasma membrane
and cytoplasmic intensities. Using the free-hand tool on the image J soft-
ware, regions on the plasmamembrane or the cytoplasm in the cell image
were selected. Using the analyze tool, the intensity and the area of the
selected regionwere obtained to calculate the intensity per pixel. Likewise,
multiple regions on the plasma membrane and the cytoplasm (up to 6
regions) were selected to obtain the average plasma membrane intensity
per pixel and average cytoplasmic intensity per pixel, respectively. These
averaged values were used to calculate the ratio [plasmamembrane inten-
sity/(plasma membrane  cytoplasmic intensity)] for quantification of
plasmamembrane and cytoplasmic distributions ofMARVVP40 and also
for assessment of localization.
For the rapamycin-induced phosphoinositide depletion system (28),
Cos-7 cells were transfected with Lyn11-FRB-CFP; (PJ-WT, INPP5E,
Sac1, or PJ-Dead)-FKBP-mRFP; and either PLC-PH-EGFP, R-Pre–GFP,
or EGFP-MARV-VP40. Fourteen hours posttransfection, cells were
treated with 1 M (final concentration) rapamycin (Sigma) for 7 min
during imaging on aZeiss LSM710 as described above. Cell images at time
zero and at 7 min were analyzed as described previously to obtain the
average intensity per pixel for the plasma membrane and cytoplasm at
time zero and 7min. The dissociation index was calculated for each EGFP
construct after depletion with each pseudojanin (PJ) construct as previ-
ously described by Hammond et al. (28) using the following equation:
dissociation index  (PM intensity/Cyto intensity)before/(PM intensity/
Cyto intensity)after, where PM represents plasma membrane and Cyto
represents cytoplasmic. Real-time imaging of 4 different cells was done for
each PJ construct to obtain the mean dissociation index and the standard
error of the mean.
RESULTS
Assessment of mVP40 binding to lipid vesicles that contained
PS and/or PIPs. MLV sedimentation assays are useful tools to
understand the membrane binding properties of lipid binding
proteins. In these assays, mVP40 was incubated with MLVs of
different lipid compositions to assess mVP40 lipid selectivity for
different anionic phospholipids. After incubation, the assay mix-
ture was centrifuged to pellet the MLVs. The appearance of
mVP40 in the pellet reflected the proteins that were bound to
MLVs, while the unbound mVP40 remained in the supernatant.
The results demonstrated thatmVP40 boundMLVs composed
of anionic phospholipids, such as PS and PIPs (Fig. 1). The data
indicated that vesicles containing anionic PS exhibited a 4-fold
increase inmVP40 binding compared to those composed solely of
zwitterionic phosphocholine (PC) and phosphatidylethanol-
amine (PE) (Fig. 1A and F). Additionally, mVP40 showed signif-
icant binding to MLVs that contained 5 mol% PIPs. mVP40
bound toMLVs containing PI(3)P, PI(4)P, or PI(5)P, with similar
fractions of protein bound. These results suggested mVP40 did
not significantly differentiate between the positions of the phos-
phate group on the inositol moiety (Fig. 1A, B, and F). When
MLVs containing both 20% PS and 5% PIP were employed,
mVP40 association with the membranes was significantly in-
creased, and the effects of both PS and PIP were additive. mVP40
showed similar patterns of bindingwithMLVs containing 5mol%
phosphatidylinositol bisphosphates [PI(3,4)P2, PI(4,5)P2, or
PI(3,5)P2] and phosphatidylinositol trisphosphate [PI(3,4,5)P3]
in the presence or absence of PS (Fig. 1C to F). These data sug-
gested thatmVP40 lacked specificity for a particular anionic phos-
FIG 1 Assessment of mVP40 association with lipid vesicles containing different PIPs or PS. (A to E) SDS-PAGE of supernatant (SN) and pellet (P) fractions
collected from MLV sedimentation assays on lipid compositions shown above the gels. In all liposomes, 30 mol% of PE was used, and when shown, 5 mol%
phosphoinositide or 20 mol% PS was used to maintain consistency. Thus, control vesicles consisted of 70 mol% POPC and 30% POPE. PS or PIPs were then
added to the vesicles at the expense of POPC. (F) Quantification of MLV sedimentation assay results using Image J. The data represent the averages of three
sedimentation assays, with the error bars representing the standard errors of the mean. *, P	 0.05.
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pholipid but demonstrated increased association with mem-
branes as the anionic charge density present in the membranes
increased.
If mVP40 lipid binding is indeed dependent on the anionic
charge density, mVP40 should exhibit increased association with
MLVs in response to the concentration gradient of anionic phos-
pholipids. Therefore, we examined mVP40 interactions with
MLVs as the concentration of PS was increased from 10 mol% to
70 mol%. As we hypothesized, a gradual increase in mVP40 asso-
ciation with the MLVs was observed as the PS concentration in-
creased, reaching saturation of the binding signal when the PS
concentration reached 40 to 50 mol% (Fig. 2A and E). Next, we
determined the mVP40 fraction bound with other anionic phos-
pholipid gradients, PA, PI(4)P, and PI(4,5)P2. All of these anionic
phospholipids promoted mVP40 association as their concentra-
tions were increased (Fig. 2B to D). mVP40 demonstrated satura-
tion in associationwithMLVswhen the PA concentration reached
30 mol% (Fig. 2B and E) and when the PI(4,5)P2 concentration
reached 7.5mol% (Fig. 2D andE). The difference in the saturation
concentrations of these anionic phospholipids reflects the
amounts of anionic charges they carry at physiological pH. PS
carries a single charge, PI(4)P has approximately 3, and PI(4,5)P2
has approximately 4 anionic charges at pH 7.4 (53). PA in the
presence of PE favors the fully deprotonated form and therefore
carries two anionic charges (54). Therefore, taking the respective
anionic charges present on these different phospholipids into ac-
count, we replotted themVP40 association with themembrane as
a function of the percent anionic charge present on the MLVs.
After the charge correction, the binding curves nearly overlapped
(Fig. 2F). These results confirmed that mVP40 did not discrimi-
nate between anionic phospholipid head groups and bound lipid
membranes as a function of anionic charge density.
In order to ensure that the 30% POPE was not causing signif-
icant phase changes in MLVs, we used laurdan steady-state fluo-
rescence experiments to probe the membrane structures of the
MLVs we used for sedimentation assay experiments (55–58). We
did observe a slight blue shift in the laurdan assay when POPEwas
present in the MLVs (data not shown), but this change was not
significant, as the general polarization valueswere indicative of the
liquid disordered phase (data not shown). We also used surface
plasmon resonance (SPR)measurements to determine if the pres-
ence of POPE significantly influenced binding ofmVP40 tomem-
branes containing POPS. The apparentKd (dissociation constant)
values for mVP40 with POPC-POPS (80:20) or POPC-POPE-
POPS (60:20:20) were very similar (
1,500 nM and
1,850 nM,
respectively, at pH 7.4 and 150mMKCl) (data not shown). Under
similar conditions, the apparent Kd of eVP40 has been reported
to be 
300 nM, suggesting eVP40 may have higher apparent
affinity for POPS-containing vesicles under similar assay con-
ditions (24, 59).
Plasmamembrane localization ofMARVVP40 is dependent
upon the anionic charge of the cytoplasmic leaflet.Next, we ex-
amined the importance of the net anionic charge present on the
plasma membrane inner leaflet in live COS-7 cells for mVP40
localization. Sphingosine, which carries a single positive charge,
has been shown previously to neutralize the anionic charge of the
plasmamembrane (27). Delivery of sphingosine induced a signif-
icant loss of plasma membrane localization of proteins that inter-
act with the plasma membrane based upon the anionic charge
density but not of those proteins that specifically coordinate a lipid
FIG 2 MARVVP40 association with anionic membranes is nonspecific and charge dependent. (A to D) SDS-PAGE of supernatant (SN) and pellet (P) fractions
collected fromMLV sedimentation assays on lipid compositions shown above the gels. In all liposomes, 30 mol% POPE was used to maintain consistency, and
POPC levels were changed accordingly when anionic lipid was added. (E) Quantification of MLV sedimentation assay data for PS, PA, PI(4)P, and PI(4,5)P2
concentration gradients. The data represent the averages of at least three sedimentation assays, with the error bars representing the standard errors of the mean.
(F) Fractions of proteins bound to MLVs as a function of the amount of anionic charge present on the vesicles.
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head group, such as PS or PIP2, for cellular localization (27, 60).
We delivered sphingosine to the cells expressing EGFP-MARV
VP40 in an attempt to neutralize the plasma membrane anionic
charge. The delivery of sphingosine neutralized the plasma mem-
brane negative charge successfully, as shown by the significant
plasma membrane dissociation of the membrane charge sensor
KR-, as previously reported (27) (Fig. 3). Similarly, EGFP-
mVP40 exhibited a marked decrease in plasmamembrane associ-
ation in the presence of sphingosine, with redistribution to inter-
nal membranes. Redistribution of mVP40 from the plasma
membrane to cytoplasmic membranes was not unexpected, be-
cause mVP40 is trafficked to the plasma membrane using an ex-
tensive network of internal membranes (14), and upon dissocia-
tion from the plasma membrane, it appears to reassociate with
these internalmembranes. This suggested thatmVP40 association
with the host cell plasma membrane is dependent on anionic
charge sensing (Fig. 3).
We also monitored the effect of sphingosine on mVP40 inter-
actions with membranes in vitro, using the MLV sedimentation
assays. In these experiments, we measured the change in binding
following incorporation of the positively charged sphingosine
intoMLVs that contained 30% POPS versus the effect of incorpo-
rating electrically neutral lipid molecules, such as diacylglycerol
(DAG). The MLV assay results supported our cell-based assay
data, as the incorporation of sphingosine into the MLVs led to
marked reduction in the fraction of mVP40 that was associated
with theMLVs (Fig. 3C and D). Incorporation of electrically neu-
tral DAG did not decrease mVP40 association with MLVs that
contained 30% POPS.
Increasing salt concentrations reduce electrostatic interac-
tions betweenmVP40 and anionicmembranes. The cellular and
in vitro data examined above suggested mVP40 is an anionic
charge sensor and is dependent on the anionic charge of themem-
brane to mediate its electrostatic interactions. To examine the
effects of the salt concentration, which can influence electrostatic
interactions, we monitored mVP40 binding to MLVs containing
30 mol% POPS in buffer containing increasing concentrations of
KCl, from150mMto 1M.As theKCl concentrationwas increased
from a physiological level of
150mM to just 300mM, binding of
mVP40 diminished by approximately 2.5-fold (Fig. 4). The ability
of a moderately high salt level to inhibit mVP40 membrane asso-
ciation strongly suggests that MARV VP40 interaction with lipid
membranes is heavily dependent on electrostatic interactions.
Plasmamembrane localization ofmVP40 is partially depen-
dent on PI(4,5)P2. The plasmamembrane inner leaflet contains a
constitutive pool of PI(4,5)P2 (29), as well as PI(4)P (28) and PIP3
(61). In order to assess the importance of PI(4,5)P2, which is the
most abundant of the three PIPs in the plasma membrane inner
leaflet and has also been implicated in other viral matrix protein
interactions (40, 43, 44, 62), we monitored mVP40 localization in
cells expressing a polyphosphoinositide 5-phosphatase IV (5-
PtaseIV) and a catalytically inactive construct. The 5-PtaseIV se-
lectively depletes plasma membrane PI(4,5)P2 by hydrolyzing the
phosphate group in the 5= position of the inositol moiety, produc-
ing PI(4)P (44, 47, 63). It has been reported that there is an
15-
fold reduction in intracellular PI(4,5)P2 levels in 293 cells that
overexpress 5-PtaseIV (47). If a protein specifically binds to a
PI(4,5)P2 head group, depletion of the PI(4,5)P2 pool leads to
FIG 3 MARV VP40 plasma membrane localization and membrane binding with and without charge neutralization. (A) COS-7 cells expressing fluorescent
fusion constructs of EGFP-mVP40 or mRFP–KR- after 2 h of treatment with vehicle (ethanol) or 75 M sphingosine. Scale bar, 5 m. (B) COS-7 cells were
quantified for plasmamembrane localization (see Materials andMethods) for the respective constructs following treatment with vehicle or 75M sphingosine.
Three independent experiments were performed, and the error bars represent standard errors of the mean. *, P	 0.0001. (C) SDS-PAGE of supernatant (SN)
and pellet (P) fractions collected from MLV sedimentation assays on lipid compositions shown above the gel. In all liposomes, 30 mol% POPE was used to
maintain consistency, and the POPC levels were scaled accordingly when POPS or sphingosine was incorporated. (D) Quantification of MLV sedimentation
assay results. The data represent the averages of three sedimentation assays, with the error bars representing the standard errors of the mean. *, P	 0.05.
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dissociation of that protein from the plasma membrane, as is the
case for the PLC-PH domain. The PH domain of this protein
construct is specific for PI(4,5)P2, and depletion of the PI(4,5)P2
pool caused nearly complete dissociation from the plasma mem-
brane (Fig. 5). For mVP40, depletion of the PI(4,5)P2 pool led to
only a small but statistically significant reduction in the plasma
membrane localization (Fig. 5). A small degree of dissociation of
mVP40 from the plasma membrane compared to PLC-PH re-
flects the loss of some anionic charges from the membrane due to
depletion of the PI(4,5)P2 pool (Fig. 5). A similar pattern of re-
FIG 4 Increasing salt concentrations (KCl) diminished MARV VP40 association with anionic membranes. (A) SDS-PAGE of supernatant (SN) and pellet (P)
fractions collected from MLV sedimentation assays that were performed in buffers that contained different KCl concentrations, as noted above the gel. All the
liposomes consisted of POPC-POPE-POPS (40:30:30). (B) Quantification of MLV sedimentation assay results. The bars represent fractions of MARV VP40
associated with MLVs under different concentrations of KCl. The data represent the averages of three sedimentation assays, with the error bars representing the
standard errors of the mean. *, P	 0.05.
FIG 5 mVP40 plasma membrane localization in the presence of active or catalytically inactive 5-PtaseIV. (A) COS-7 cells expressing GFP fluorescent fusion
constructs of MARV VP40, KR--mRFP, or PLC-PH are shown 12 h posttransfection. The cells were cotransfected with active or a catalytically inactive
(deletion mutant) 5-PtaseIV construct. Scale bars, 5 m. (B) COS-7 cells were quantified for the average plasma membrane localization for the respective
constructs in the presence of active 5-PtaseIV (light bars) or catalytically inactive 5-PtaseIV (dark bars). Three independent experiments were performed to
determine the average localization and standard error of the mean. *, P	 0.0001.
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duction was observed for plasma membrane localization of the
anionic charge sensor KR- (Fig. 5). Observing similar trends
between mVP40 and the KR- protein further strengthened our
conclusion that mVP40 behaves as an anionic charge sensor.
Next, we used a rapamycin-inducible PI(4,5)P2 and PI(4)P de-
pletion system generated by Hammond et al. to further confirm
our observations on mVP40. The rapamycin-based PIP depletion
can be used in real time to observe the effect of depleting
PI(4,5)P2, PI(4)P, or both at the plasma membrane inner leaflet
on target proteins. The PJ-WT construct contains 5-phosphatase
(INPP5E) and 4-phosphatase (Sac1) and causes rapid depletion of
plasma membrane PI(4,5)P2 and PI(4)P levels by hydrolyzing to
PI upon recruitment of the PJ construct to the plasma membrane
following addition of rapamycin. Proteins such as PLC-PH,
which is specific to PI(4,5)P2, show a sharp decrease in plasma
membrane localization due to lack of substrate for its interaction,
as shown in Fig. 6. R-Pre, another known anionic charge sensor
(64), was used with the rapamycin-based PIP depletion system to
compare charge-dependent behavior to that of mVP40. With
mVP40, the effect of PJ-WT recruitment to the plasmamembrane
was about 2-fold lower in its dissociation index than that observed
for PLC-PH (Fig. 6). This again suggests that mVP40 is depen-
dent on the anionic charge at the plasma membrane due to the
enrichment of PI(4,5)P2 and PI(4)P, which are hydrolyzed under
the conditions of PJ-WT recruitment, but not to the level of
PLC-PH displacement, as the PS and PI retained in the plasma
membrane likely have sufficient anionic charge to mediate some
of the mVP40 membrane association. mVP40 dissociation under
these conditions was increased relative to the 5-PtaseIV depletion
system, as under the rapamycin PJ-WT condition, both PI(4,5)P2
and PI(4)P levels were drastically reduced (Fig. 5 and 6). With the
PJ-WT depletion system, mVP40 and R-Pre displayed similar de-
grees of dissociation from the plasma membrane following addi-
tion of rapamycin (the plasmamembrane dissociation indexes for
mVP40 and R-Pre were 3.56 and 3.2, respectively) (Fig. 6).
The PJ-INPP5E construct, which contains the active 5-phos-
phatase and inactive 4-phosphatase, hydrolyzes PI(4,5)P2 to
PI(4)P and was used to assess PLC-PH, mVP40, and R-Pre
plasma membrane dissociation following rapamycin addition
(Fig. 6). The effect of depletion of PI(4,5)P2 to PI(4)P also greatly
induced dissociation of PLC-PH from the plasma membrane
(Fig. 6).mVP40 andR-Pre also dissociated from the plasmamem-
brane when PI(4,5)P2 was selectively depleted to PI(4)P by PJ-
INPP5E but not to the same extent as when both PI(4,5)P2 and
FIG 6 Changes in MARV VP40 localization in response to the real-time recruitment of different lipid phosphatase constructs to the plasma membrane inner
leaflet. (A) Cos-7 cells expressing fluorescent fusion constructs ofMARVVP40, PLC-PH, or R-Pre are shown 14 h posttransfection. The cells were cotransfected
with a PJ-WT, PJ-INPP5E, PJ-SacI, or PJ-Dead construct, as well as a Lyn11 plasmamembrane anchor. Pre-Rapa, images taken before the addition of rapamycin;
Post-Rapa, images taken 7 min after addition of rapamycin. Scale bar, 5 m. (B) Four independent real-time imaging experiments were performed for each
construct to determine the standard error of the mean for each dissociation index (n 4; confidence interval [CI] 98%; ns, not significant; *, P	 0.02). The
plasma membrane dissociation index was calculated as described in Materials and Methods using the following equation: dissociation index (PM intensity/
Cyto intensity)before/(PM intensity/Cyto intensity)after.
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PI(4)P were depleted with PJ-WT. The fold decreases in the dis-
sociation index were similar for mVP40 and PLC-PH when PJ-
INPP5E data were compared to those of PJ-WT (Fig. 6). Under
conditions of PJ-INPP5E activity, PI(4)P levels are presumably
still intact to allow for more PI(4,5)P2 formation from PI(4)P by
the PI(4)P 5-kinase. Additionally, the total plasmamembrane an-
ionic content is lowered only by removal of the 5-phosphate sup-
porting the more significant plasma membrane retention of
mVP40 and R-Pre compared to the PJ-WT experiments. The
lower dissociation index for R-Pre than formVP40 for PJ-INPP5E
experiments may be due to the lipidation present on the R-Pre
protein that can interact with acyl chains of phospholipids and
provide additional stability to R-Pre at the plasma membrane.
Next, we employed a construct with an active 4-phosphatase
but an inactive 5-phosphatase, PJ-Sac1, which has been shown to
selectively deplete plasmamembrane PI(4)P following rapamycin
addition. Under these conditions, the PLC-PH plasma mem-
brane dissociation was not affected, as PI(4)P is hydrolyzed to PI
(Fig. 6). However, PJ-Sac1 activity did induce dissociation of
mVP40 from the plasma membrane to a similar degree as the
PJ-INPP5E construct. This is also consistent with the principle
that PJ-Sac1 and PJ-INPP5E reduce the plasma membrane an-
ionic charge to similar degrees (i.e., removal of one phosphate
each). R-Pre also had a statistically significant increase in dissoci-
ation from the plasma membrane when PJ-Sac1 was active and to
a level similar to that of the PJ-INPP5E-induced dissociation.
Once again, the lower dissociation index of R-Pre can be attrib-
uted to its lipid anchor. A catalytically inactive 5-phosphatase and
4-phosphatase construct, PJ-DEAD, was also used as a negative
control to compare and normalize the dissociation index for each
construct (Fig. 6).
The cell-based data collected here are consistent with the in
vitro data, suggesting broad binding to anionic lipids by mVP40,
which includes PS, PI(4,5)P2, and possibly PI(4)P and PA en-
riched on the plasmamembrane inner leaflet. Taken together, the
in vitro and cellular experiments demonstrated thatmVP40 is pro-
miscuous in its selectivity for anionic phospholipids and is amem-
brane anionic charge sensor.
Cholesterol enhances association ofMARVVP40withmem-
branes that contain PS. It has been reported that HIV-1 GAG,
which contains the matrix lipid binding domain, shows enhanced
association with membranes that contain cholesterol (41). We
investigated if cholesterol was able to enhance binding of mVP40
using the MLV sedimentation assay. First, we increased the cho-
lesterol content of MLVs that contained 20% POPS from 0% to
50%, which is below the solubility limit of cholesterol in POPC-
and POPE-containing vesicles (41, 65). As the cholesterol content
increased,mVP40 associationwith themembranes also increased,
reaching a maximum binding level at 
40% cholesterol content
in theMLVs (Fig. 7 A, B, and E).Next, we removed POPS from the
MLVs to investigate ifmVP40 responds to the cholesterol gradient
in the absence of anionic lipids. As shown in Fig. 7,mVP40 did not
significantly associate with MLVs containing increasing concen-
trations of cholesterol but devoid of POPS (Fig. 7C, D, and E).
This again suggests the necessity for anionic charge at the mem-
brane to recruit mVP40 via electrostatic interactions. The in-
creased association of mVP40 in the presence of cholesterol may
be due to the phenomenon known as the “cholesterol condensa-
tion effect” (41, 66). Increasing concentrations of cholesterol re-
sult in tighter packing of acyl chains, causing the phospholipid
head groups to pack closely, as well. As a result of the increase in
the packing density of phospholipid head groups, clustering of
anionic POPS in the membranes may appear to be greater than in
the absence of cholesterol. This apparent increase in regions of
FIG 7 Influence of cholesterol onMARVVP40 association with POPS-containingmembranes. (A to D) SDS-PAGE of supernatant (SN) and pellet (P) fractions
collected fromMLV sedimentation assays on lipid compositions shown above the gels. In all liposomes, 30mol%POPEwas used, andwhenmentioned, 20mol%
POPS was used to maintain consistency. (A and B) MARV VP40 shows enhanced association with MLVs that contain 20% POPS in response to the cholesterol
(Chol) gradient. (C and D) Cholesterol in the absence of POPS does not promote significant association of mVP40 with MLVs. (E) Quantification of MLV
sedimentation assay results with Image J. The data represent the averages of three sedimentation assays, with the error bars representing the standard errors of
the mean. CI 95%.
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anionic charge density is likely sufficient to recruit mVP40 and
hence cause an increase inmembrane association at lower levels of
POPS.
DISCUSSION
Despite the discovery of MARV in 1967 (2, 67, 68), little informa-
tion is available on its matrix protein interactions with host pro-
teins or lipids. To our knowledge, we present the first analysis of
mVP40 interactions with lipids. Here, we found that mVP40 as-
sociates with membranes using nonspecific electrostatic interac-
tions and that the binding saturates at a negative charge density of

40 to 45%, regardless of the lipid head group employed. This
mechanism was responsible for the plasma membrane localiza-
tion of mVP40, as neutralization of the plasma membrane charge
led to redistribution of mVP40 to internal membranes.
The first clue to mVP40 promiscuity in its interaction with
anionic phospholipids came fromMLV assay data that examined
association withmembranes that contain 20%PS and 5%PIPs. In
this data set, we observed that mVP40 associated similarly with
vesicles containing three different types of monophosphates
[PI(3)P, PI(4)P, and PI(5)P]. mVP40 behaved similarly when the
bisphosphate derivatives of PIPs [PI(3,4)P2, PI(4,5)P2, and
PI(3,5)P2] were employed. Here, mVP40 associated similarly, re-
gardless of the position of the phosphate groups. Similarly, when
PIP3 was included in the vesicles, mVP40 demonstrated a further
increase in binding compared to the bisphosphates. Further, when
20% PS and 5% PIPs were included in the same vesicles, the com-
bined effect of PS andPIPswas additive, further suggesting depen-
dency on the membrane anionic charge density for mVP40 bind-
ing.
The notion of mVP40 functioning as an anionic charge sensor
was further validated with overlap of the mVP40 binding curves
with different anionic phospholipids [PS, PA, PI(4)P, and
PI(4,5)P2] following their charge correction. In vitro assay data
were supported with live-cell assays using sphingosine, where
neutralization of the plasma membrane negative charge caused a
dramatic reduction in localization of mVP40. Depletion of the
PI(4,5)P2 pool in the plasmamembrane by 5-PtaseIV reduced the
plasma membrane localization of mVP40, but by 
18% com-
pared to an 
54% reduction for PLC-PH. Reduction of the
plasmamembrane localization for the known anionic charge sen-
sor KR- due to 5-PtaseIV was
16%, which is very similar to the
dissociation shown by mVP40. Moreover, the background GFP
signal at the plasma membrane for PLC-PH when PI(4,5)P2 is
depleted was comparable to that of GFP alone. This suggested that
mVP40 lacks stereospecific interaction with PI(4,5)P2 in the
plasma membrane and behaves more like KR-, which associates
with the plasma membrane in an electrostatic manner devoid of
any stereospecific association. Rather, the modest but statistically
significant reduction in mVP40 plasma membrane localization
was due to the loss of the anionic charge contribution by the phos-
phate group on the 5= position of the inositol moiety on PI(4,5)P2
(Fig. 5 and 6). This loss of a single phosphate group results in loss
of additional anionic charge. However, the pool of PI(4,5)P2 is
likely to be 3 to 5 mol% in the plasma membrane, and although
the contribution of anionic charges from PI(4,5)P2 to the plasma
membrane is significant, PSmay be found at 15 to 20mol% of the
plasma membrane inner leaflet and represents 
30% of the an-
ionic charge. This 30% anionic charge is similar to the level of
charge that would promote
75 to 85% mVP40 binding in vitro.
From the recent crystal structure of themVP40 dimer (26), the
CTD harbors the purported lipid binding surface or the basic
patch of the protein. The mVP40 dimer is flatter and contains a
basic patch larger than that of eVP40. The positively charged side
chains of Arg and Lys residues comprising the basic patch seem to
project outward and away from the flat surfaces of the CTD do-
mains of the mVP40 dimer. These structural features of mVP40
are consistent with the membrane interaction data we found in
this study. The cationic amino acid side chains that project away
from the CTD surface provide ideal sites to form salt bridges with
the anionic phospholipid head groups and mediate membrane
interactions. Our data support the idea that mVP40 interactions
with the membrane rely heavily on electrostatic effects, which is
further supported in the structural analysis, where singlemutation
of Lys210 to Glu abrogated VLP formation (26). Moreover, we
have demonstrated that the K210E construct binding to vesicles
containing PS was 
30% reduced while binding of double and
triple mutations of the mVP40 cationic patch was nearly fully
abrogated (26). Binding of mVP40 was also restored by a K210R
construct, further suggesting that nonspecific electrostatic inter-
actions play an important role in membrane association, as Arg
seemed to substitute for Lys in vitro and in cells (26). Additionally,
abrogation of the mVP40 dimer interface (T105R mutation) sig-
nificantly reduced binding to vesicles containing PS, suggesting
the extensive cationic patch provided by twoCTDswhen theVP40
dimer is intact (26) is necessary for anionic charge sensing. The
lipid binding studies with T105R further suggested that the non-
specific electrostatic association observed for mVP40 in the study
was not simply due to lack of proper folding of the CTD domain
and subsequent nonspecific binding. These data again underscore
the need for multiple electrostatic interactions between lipid head
groups in the plasma membrane and the cationic patch in the
mVP40 dimer (26). While targeting nonspecific electrostatic in-
teractions would be difficult therapeutically (69), staurosporines
(70–72), derivatives of which are in clinical trial (73, 74), have
been shown to block endosomal sorting and recycling of PS. This
decreased the plasma membrane PS pool and altered the localiza-
tion of proteins dependent on electrostatic interactions with the
plasma membrane (71, 72).
While some structure-function data on eVP40 are available,
almost nothing is known about mVP40 membrane interactions.
Comparison of the eVP40 and mVP40 sequences revealed amino
acid sequence identity of 34%, with even less identity in the CTD
membrane binding region. These sequence dissimilarities seem to
contribute to the different lipid binding properties of eVP40 and
mVP40. Previous studies have demonstrated that eVP40 can as-
sociate with vesicles containing PS (20, 22–24, 38). While these
previous studies have not discriminated between specific and
nonspecific electrostatic interactions with PS, more detailed ex-
periments with PS interactions in cell culture have demonstrated
that PS plays an important and specific role in interacting with
eVP40 (59, 60). Additionally, treatment of human and mamma-
lian cell lines expressing eVP40 with sphingosine did not have a
significant effect on eVP40 plasma membrane localization (59,
60). These studies have strongly suggested that eVP40 membrane
association is not a simple case of anionic charge sensing. This
suggests that thoughmVP40 and eVP40 both rely heavily on elec-
trostatic interactions for membrane association, there is a funda-
mental difference between the two proteins’mechanismof assem-
bly at the plasma membrane. Many peripheral proteins rely on
Wijesinghe and Stahelin
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more than electrostatic interactions for membrane targeting (75),
and while it is quite possible the mVP40 dimer electrostatic inter-
actions with the plasma membrane are sufficient to drive NTD
displacement and mVP40 oligomerization, further biophysical
analysis is warranted to understand the mechanisms of lipid-pro-
tein and protein-protein interactions that regulate the mVP40
matrix assembly.
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